In vitro and in vivo experiments demonstrated that IL‐33 and BTZ synergistically exerted anti‐MM efficacy via stimulating excessive accumulation of ROS, thereby attenuating NF‐κB signal and suppressing stemness properties of MM cells. This evidence concerns the gene CASC3 and Miyoshi myopathy.